Sees Q4 realized EPS growth of high single digits in back half of the year. Says expects revenue and EPS growth to accelerate in Q4. Comments and guidance taken from Q3 earnings conference call.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- MDT Earnings: Medtronic Diabetes and Heart Devices Drive Beat
- Options Volatility and Implied Earnings Moves Today, February 18, 2025
- Medtronic backs FY25 EPS view $5.44-$5.50, consensus $5.45
- Medtronic reports Q3 EPS $1.39, consensus $1.36
- Options Volatility and Implied Earnings Moves This Week, February 17 – February 20, 2025